Table 1.
General characteristics of the patients and controls
| |
Control |
CAD patients |
P
|
|---|---|---|---|
| (n = 15) | (n = 25) | ||
| Gender |
|
|
0.7360 |
| Male (%) |
10 (67.70) |
18 (72.00) |
|
| Female (%) |
5 (32.30) |
7 (28.00) |
|
| Age (years) |
64.73 ± 3.00 |
67.36 ± 2.00 |
0.3469 |
| BMI, kg/m2 |
23.10 ± 0.43 |
22.53 ± 0.37 |
0.3289 |
| SBP, mm Hg |
160.70 ± 4.00 |
161.00 ± 4.00 |
0.9438 |
| DBP, mm Hg |
91.40 ± 3.00 |
92.80 ± 3.00 |
0.8707 |
| Creatinine, μmol/L |
84.41 ± 6.17 |
109.6 ± 22.25 |
0.3943 |
| Homocysteine, μmol/L |
10.9400 ± .73 |
16.3400 ± 1.47 |
0.004 |
| fasting blood-glucose (mmol/L) |
7.06 ± 0.78 |
6.03 ± 0.40 |
0.1131 |
| Triglyceride, ìmol/L |
2.45 ± 0.48 |
1.97 ± 0.24 |
0.3320 |
| Total cholesterol, ìmol/L |
4.49 ± 0.24 |
4.53 ± 0.20 |
0.8967 |
| LDL-C, mmol/L |
2.65 ± 0.31 |
2.80 ± 0.43 |
0.8966 |
| Positive history of diabetes (%) |
5(40) |
4(16) |
0.2550 |
| Positive history of smoking (%) |
3(20) |
9(36) |
0.4770 |
| Positive history of drinking (%) | 3(20) | 11(44) | 0.1770 |